134 related articles for article (PubMed ID: 12959184)
1. Surgical advances in the treatment of ovarian cancer.
Li AJ; Karlan BY
Hematol Oncol Clin North Am; 2003 Aug; 17(4):945-56. PubMed ID: 12959184
[TBL] [Abstract][Full Text] [Related]
2. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
3. Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
Leeper K; Garcia R; Swisher E; Goff B; Greer B; Paley P
Gynecol Oncol; 2002 Oct; 87(1):52-6. PubMed ID: 12468342
[TBL] [Abstract][Full Text] [Related]
4. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
5. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
7. [Fertility-sparing surgery in borderline ovarian tumours].
Pehlivanov B; Iamakov K; Ivancheva H
Akush Ginekol (Sofiia); 2015; 54(1):21-6. PubMed ID: 25909126
[TBL] [Abstract][Full Text] [Related]
8. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
Carcangiu ML; Peissel B; Pasini B; Spatti G; Radice P; Manoukian S
Am J Surg Pathol; 2006 Oct; 30(10):1222-30. PubMed ID: 17001151
[TBL] [Abstract][Full Text] [Related]
9. Fertility preservation in young women with epithelial ovarian cancer.
Wright JD; Shah M; Mathew L; Burke WM; Culhane J; Goldman N; Schiff PB; Herzog TJ
Cancer; 2009 Sep; 115(18):4118-26. PubMed ID: 19670446
[TBL] [Abstract][Full Text] [Related]
10. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
11. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
[TBL] [Abstract][Full Text] [Related]
12. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic cytoreduction for primary advanced ovarian cancer.
Fanning J; Hojat R; Johnson J; Fenton B
JSLS; 2010; 14(1):80-2. PubMed ID: 20529532
[TBL] [Abstract][Full Text] [Related]
14. Role of surgery in ovarian carcinoma.
Fader AN; Rose PG
J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
Olivier RI; van Beurden M; Lubsen MA; Rookus MA; Mooij TM; van de Vijver MJ; van't Veer LJ
Br J Cancer; 2004 Apr; 90(8):1492-7. PubMed ID: 15083174
[TBL] [Abstract][Full Text] [Related]
16. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Callahan MJ; Crum CP; Medeiros F; Kindelberger DW; Elvin JA; Garber JE; Feltmate CM; Berkowitz RS; Muto MG
J Clin Oncol; 2007 Sep; 25(25):3985-90. PubMed ID: 17761984
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
Casey MJ; Bewtra C
Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
[TBL] [Abstract][Full Text] [Related]
18. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
